| 1 | [SID24831701] | Active | IC50 | 7.22 | Inhibitors of Plasmodium falciparum M1- Family Alanyl Aminopeptidase (M1AAP) [AID1445, Type: confirmatory] | m1-family aminopeptidase [Plasmodium falciparum 3D7] [gi:124512980] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | IC50 | 7.22 [uM] | | BioAssay | Inhibitors of Plasmodium falciparum M1- Family Alanyl Aminopeptidase (M1AAP) | | AID | 1445 | | BioAssay type | confirmatory | | Target | m1-family aminopeptidase [Plasmodium falciparum 3D7] [gi:124512980] | | PubMed | | | Data Table |  |
|
| 2 | [SID24831701] | Active | IC50 | 7.22 | Inhibitors of Plasmodium falciparum M1- Family Alanyl Aminopeptidase (M1AAP) [AID1445, Type: confirmatory] | m1-family aminopeptidase [Plasmodium falciparum 3D7] [gi:124512980] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | IC50 | 7.22 [uM] | | BioAssay | Inhibitors of Plasmodium falciparum M1- Family Alanyl Aminopeptidase (M1AAP) | | AID | 1445 | | BioAssay type | confirmatory | | Target | m1-family aminopeptidase [Plasmodium falciparum 3D7] [gi:124512980] | | PubMed | | | Data Table |  |
|
| 3 | [SID24831701] | Active | Potency | 31.6228 | qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease [AID2242, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease | | AID | 2242 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 4 | [SID24831701] | Active | Potency | 31.6228 | qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease [AID2242, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease | | AID | 2242 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 5 | [SID24831701] | Active | Potency | 31.6228 | qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease [AID2242, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease | | AID | 2242 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 6 | [SID24831701] | Active | | | HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype [AID759, Type: screening] | ras protein [Homo sapiens] [gi:190938] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | BioAssay | HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype | | AID | 759 | | BioAssay type | screening | | Target | ras protein [Homo sapiens] [gi:190938] | | PubMed | | | Data Table |  |
|
| 7 | [SID24831701] | Active | | | HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype [AID759, Type: screening] | ras protein [Homo sapiens] [gi:190938] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | BioAssay | HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype | | AID | 759 | | BioAssay type | screening | | Target | ras protein [Homo sapiens] [gi:190938] | | PubMed | | | Data Table |  |
|
| 8 | [SID24831701] | Active | | | HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype [AID759, Type: screening] | ras protein [Homo sapiens] [gi:190938] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | BioAssay | HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype | | AID | 759 | | BioAssay type | screening | | Target | ras protein [Homo sapiens] [gi:190938] | | PubMed | | | Data Table |  |
|
| 9 | [SID24831701] | Active | | | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts [AID588335, Type: screening] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts | | AID | 588335 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID24831701] | Active | | | Counterscreen for activators of kallikrein-7 (K7) zymogen: Fluorescence intensity-based biochemical high throughput counterscreen assay for activators that optically interfere with measurement of EDANS-DABCYL fluorescence [AID686952, Type: screening] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | BioAssay | Counterscreen for activators of kallikrein-7 (K7) zymogen: Fluorescence intensity-based biochemical high throughput counterscreen assay for activators that optically interfere with measurement of EDANS-DABCYL fluorescence | | AID | 686952 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID24831701] | Active | | | HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 wildtype [AID761, Type: screening] | cell division cycle 42 (GTP binding protein, 25kDa) [Homo sapiens] [gi:56202836] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | BioAssay | HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 wildtype | | AID | 761 | | BioAssay type | screening | | Target | cell division cycle 42 (GTP binding protein, 25kDa) [Homo sapiens] [gi:56202836] | | PubMed | | | Data Table |  |
|
| 12 | [SID24831701] | Active | | | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity [AID623870, Type: screening] | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | BioAssay | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 623870 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] | | PubMed | | | Data Table |  |
|
| 13 | [SID24831701] | Active | | | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity [AID623870, Type: screening] | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | BioAssay | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 623870 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] | | PubMed | | | Data Table |  |
|
| 14 | [SID24831701] | Active | | | Fluorescence Intensity-based biochemical primary high throughput confirmation assay to identify activators of kallikrein-7 (K7) zymogen [AID686949, Type: screening] | KLK7 gene product [Homo sapiens] [gi:21327705] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | BioAssay | Fluorescence Intensity-based biochemical primary high throughput confirmation assay to identify activators of kallikrein-7 (K7) zymogen | | AID | 686949 | | BioAssay type | screening | | Target | KLK7 gene product [Homo sapiens] [gi:21327705] | | PubMed | | | Data Table |  |
|
| 15 | [SID24831701] | Active | | | Fluorescence Intensity-based biochemical primary high throughput confirmation assay to identify activators of kallikrein-7 (K7) zymogen [AID686949, Type: screening] | KLK7 gene product [Homo sapiens] [gi:21327705] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | BioAssay | Fluorescence Intensity-based biochemical primary high throughput confirmation assay to identify activators of kallikrein-7 (K7) zymogen | | AID | 686949 | | BioAssay type | screening | | Target | KLK7 gene product [Homo sapiens] [gi:21327705] | | PubMed | | | Data Table |  |
|
| 16 | [SID24831701] | Active | | | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen [AID652039, Type: screening] | KLK7 gene product [Homo sapiens] [gi:21327705] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | BioAssay | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen | | AID | 652039 | | BioAssay type | screening | | Target | KLK7 gene product [Homo sapiens] [gi:21327705] | | PubMed | | | Data Table |  |
|
| 17 | [SID24831701] | Active | | | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen [AID652039, Type: screening] | KLK7 gene product [Homo sapiens] [gi:21327705] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | BioAssay | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen | | AID | 652039 | | BioAssay type | screening | | Target | KLK7 gene product [Homo sapiens] [gi:21327705] | | PubMed | | | Data Table |  |
|
| 18 | [SID24831701] | Active | | | Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation [AID1321, Type: screening] | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation | | AID | 1321 | | BioAssay type | screening | | Target | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] | | PubMed | | | Data Table |  |
|
| 19 | [SID24831701] | Active | | | Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation [AID1321, Type: screening] | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation | | AID | 1321 | | BioAssay type | screening | | Target | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] | | PubMed | | | Data Table |  |
|
| 20 | [SID24831701] | Active | | | Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation [AID1321, Type: screening] | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation | | AID | 1321 | | BioAssay type | screening | | Target | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] | | PubMed | | | Data Table |  |
|
| 21 | [SID24831701] | Active | | | HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac wildtype [AID757, Type: screening] | Rac1 protein [Homo sapiens] [gi:8574038] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | BioAssay | HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac wildtype | | AID | 757 | | BioAssay type | screening | | Target | Rac1 protein [Homo sapiens] [gi:8574038] | | PubMed | | | Data Table |  |
|
| 22 | [SID24831701] | Active | | | HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac wildtype [AID757, Type: screening] | Rac1 protein [Homo sapiens] [gi:8574038] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | BioAssay | HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac wildtype | | AID | 757 | | BioAssay type | screening | | Target | Rac1 protein [Homo sapiens] [gi:8574038] | | PubMed | | | Data Table |  |
|
| 23 | [SID24831701] | Active | | | qHTS Assay for Inhibitors of the CtBP/E1A Interaction [AID651724, Type: screening] | CtBP interacting protein CtIP [Homo sapiens] [gi:1730321] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of the CtBP/E1A Interaction | | AID | 651724 | | BioAssay type | screening | | Target | CtBP interacting protein CtIP [Homo sapiens] [gi:1730321] | | PubMed | | | Data Table |  |
|
| 24 | [SID24831701] | Active | | | qHTS Assay for Inhibitors of the Six1/Eya2 Interaction [AID651725, Type: screening] | six1 [Homo sapiens] [gi:1246761] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of the Six1/Eya2 Interaction | | AID | 651725 | | BioAssay type | screening | | Target | six1 [Homo sapiens] [gi:1246761] | | PubMed | | | Data Table |  |
|
| 25 | [SID24831701] | Active | | | HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab2 wildtype [AID760, Type: screening] | Ras-related protein Rab-2 [gi:46577642] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | BioAssay | HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab2 wildtype | | AID | 760 | | BioAssay type | screening | | Target | Ras-related protein Rab-2 [gi:46577642] | | PubMed | | | Data Table |  |
|
| 26 | [SID24831701] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the DAF-12 from the parasite H. glycines (hgDAF-12). [AID687014, Type: screening] | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the DAF-12 from the parasite H. glycines (hgDAF-12). | | AID | 687014 | | BioAssay type | screening | | Target | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] | | PubMed | | | Data Table |  |
|
| 27 | [SID24831701] | Active | | | Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA) [AID651718, Type: screening] | MSRA protein [Bos taurus] [gi:73586699] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | BioAssay | Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA) | | AID | 651718 | | BioAssay type | screening | | Target | MSRA protein [Bos taurus] [gi:73586699] | | PubMed | | | Data Table |  |
|
| 28 | [SID24831701] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis [AID588726, Type: screening] | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis | | AID | 588726 | | BioAssay type | screening | | Target | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] | | PubMed | | | Data Table |  |
|
| 29 | [SID24831701] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 30 | [SID24831701] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 31 | [SID24831701] | Inactive | Potency | 0.4467 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Inactive | | Potency | 0.4467 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID24831701] | Inactive | Potency | 9.2683 | qHTS Assay for Modulators of miRNAs and/orActivators of miR-21 [AID2288, Type: confirmatory] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Inactive | | Potency | 9.2683 [uM] | | BioAssay | qHTS Assay for Modulators of miRNAs and/orActivators of miR-21 | | AID | 2288 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID24831701] | Inactive | Potency | 10 | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Inactive | | Potency | 10 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 34 | [SID24831701] | Inactive | Potency | 10 | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Inactive | | Potency | 10 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 35 | [SID24831701] | Inactive | Potency | 25.1189 | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588456, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Inactive | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588456 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 36 | [SID24831701] | Inactive | Potency | 25.1189 | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588456, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Inactive | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588456 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 37 | [SID24831701] | Inactive | Potency | 28.1838 | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen [AID624418, Type: confirmatory] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Inactive | | Potency | 28.1838 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen | | AID | 624418 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID24831701] | Inactive | Potency | 31.6228 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Inactive | | Potency | 31.6228 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 39 | [SID24831701] | Inactive | Potency | 39.8107 | qHTS Assay for Identification of Novel General Anesthetics [AID485281, Type: confirmatory] | Chain A, Horse Spleen Apoferritin [gi:254220970] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Inactive | | Potency | 39.8107 [uM] | | BioAssay | qHTS Assay for Identification of Novel General Anesthetics | | AID | 485281 | | BioAssay type | confirmatory | | Target | Chain A, Horse Spleen Apoferritin [gi:254220970] | | PubMed | | | Data Table |  |
|
| 40 | [SID24831701] | Inactive | Potency | | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) [AID2549, Type: confirmatory] | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) | | AID | 2549 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] | | PubMed | | | Data Table |  |
|
| 41 | [SID24831701] | Inactive | Potency | | qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK) [AID1721, Type: confirmatory] | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK) | | AID | 1721 | | BioAssay type | confirmatory | | Target | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] | | PubMed | | | Data Table |  |
|
| 42 | [SID24831701] | Inactive | Potency | | qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK) [AID1722, Type: confirmatory] | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK) | | AID | 1722 | | BioAssay type | confirmatory | | Target | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] | | PubMed | | | Data Table |  |
|
| 43 | [SID24831701] | Inactive | | | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity [AID504423, Type: screening] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Inactive | | BioAssay | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504423 | | BioAssay type | screening | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 44 | [SID24831701] | Inactive | | | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) [AID588664, Type: screening] | ABL1 gene product [Homo sapiens] [gi:62362414] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Inactive | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) | | AID | 588664 | | BioAssay type | screening | | Target | ABL1 gene product [Homo sapiens] [gi:62362414] | | PubMed | | | Data Table |  |
|
| 45 | [SID24831701] | Inactive | | | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) [AID588664, Type: screening] | ABL1 gene product [Homo sapiens] [gi:62362414] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Inactive | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) | | AID | 588664 | | BioAssay type | screening | | Target | ABL1 gene product [Homo sapiens] [gi:62362414] | | PubMed | | | Data Table |  |
|
| 46 | [SID24831701] | Inactive | | | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay [AID651560, Type: screening] | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay | | AID | 651560 | | BioAssay type | screening | | Target | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] | | PubMed | | | Data Table |  |
|
| 47 | [SID24831701] | Inactive | | | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay [AID651560, Type: screening] | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay | | AID | 651560 | | BioAssay type | screening | | Target | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] | | PubMed | | | Data Table |  |
|
| 48 | [SID24831701] | Inactive | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Inactive | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 49 | [SID24831701] | Inactive | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Inactive | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 50 | [SID24831701] | Inactive | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 24831701 | | CID | 16196305 | | Outcome | Inactive | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|